Wan Sun
Wan Sun publishes mostly in Oncology, Immunology and Pulmonary and Respiratory Medicine, on topics such as Advanced Breast Cancer Therapies, Inflammatory Bowel Disease and Biosimilars and Bioanalytical Methods.
- World rank
- #2,292,789 of 7,710,434 ranked researchers
- Rank in United States
- #684,288 of 1,627,098
- Works
- 33
- Citations
- 629
- Citations per work
- 19.1
What does Wan Sun research?
Wan Sun's work is mostly in Medicine (31%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1442.8%
- Health Sciences1030.8%
- Medicine1030.8%
- Life Sciences926.4%
- 1Oncology14% of their works
- 2Immunology11% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Molecular Biology9% of their works
- 5Genetics7% of their works
- 6Infectious Diseases7% of their works
Research topics
Which keywords describe Wan Sun's research?
The keywords of their largest research topics: Breast Cancer, CDK4/6 Inhibitors, Epidemiology, Inflammatory Bowel Disease, Palbociclib, ACE2 Receptor, Crohn's Disease and SARS-CoV-2.
- Thrombosis
- Genomic Aberrations
- Collagenous Colitis
- Chronic Lymphocytic Leukemia
- HER2
- Biosimilars
- SARS-CoV-2
- ACE2 Receptor
- Inflammatory Bowel Disease
- CDK4/6 Inhibitors
- Breast Cancer
- Epidemiology
- Palbociclib
- Crohn's Disease
- Ulcerative Colitis
- Immunogenicity
- Trastuzumab
- Clinical Characteristics
- Coronavirus
- Microscopic Colitis
- Vaccine
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Breast Cancer132 topics
- CDK4/6 Inhibitors91 topic
- Epidemiology92 topics
- Inflammatory Bowel Disease92 topics
- Palbociclib91 topic
- ACE2 Receptor62 topics
- Crohn's Disease61 topic
- SARS-CoV-262 topics
- Ulcerative Colitis61 topic
- Biosimilars51 topic
- Immunogenicity51 topic
- HER241 topic
- Trastuzumab41 topic
- Chronic Lymphocytic Leukemia31 topic
- Clinical Characteristics31 topic
- Collagenous Colitis31 topic
- Coronavirus31 topic
- Genomic Aberrations31 topic
- Microscopic Colitis31 topic
- Thrombosis31 topic
- Vaccine31 topic
Where does Wan Sun work?
Wan Sun's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does Wan Sun have?
OpenAlex counts 33 works and 629 citations for Wan Sun, an h-index of 11, ranking #2,292,789 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Wan Sun
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Wan Sun. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.